Literature DB >> 7763169

Comparison of medical and minimally invasive surgical therapy for primary esophageal motility disorders.

M G Patti1, C A Pellegrini, M Arcerito, J Tong, S J Mulvihill, L W Way.   

Abstract

OBJECTIVE: To compare medical with minimally invasive surgical therapy in the treatment of primary esophageal motility disorders.
DESIGN: Prospective study.
SETTING: University-based tertiary care center. PATIENTS: Eighty-nine patients (46 men and 43 women) with either achalasia or nutcracker esophagus and diffuse esophageal spasm (DES). Choice of treatment was based not on randomization but on the preference of the referring physician, the patient's choice, and/or the patient's eligibility to access the University of California, San Francisco, for treatment.
INTERVENTIONS: Nineteen patients with achalasia and 30 patients with nutcracker esophagus and DES were treated with dilatations and/or medications. Thirty patients with achalasia and 10 with nutcracker esophagus and DES underwent a thoracoscopic myotomy. MAIN OUTCOME MEASURES: Dysphagia, pain, and overall quality of life.
RESULTS: In the surgical group, 80% of the patients with nutcracker esophagus and DES and 87% of the patients with achalasia had good or excellent results. In contrast, in the medical group, 26% of the patients with nutcracker esophagus and DES and 26% of the patients with achalasia had good or excellent results.
CONCLUSIONS: Surgery by minimally invasive techniques offers a better chance than does medical therapy or dilatation of rendering the patient with achalasia, nutcracker esophagus, and DES asymptomatic.

Entities:  

Mesh:

Year:  1995        PMID: 7763169     DOI: 10.1001/archsurg.1995.01430060047009

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  32 in total

1.  Effects of previous treatment on results of laparoscopic Heller myotomy for achalasia.

Authors:  M G Patti; C V Feo; M Arcerito; M De Pinto; A Tamburini; U Diener; W Gantert; L W Way
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

Review 2.  Distal esophageal spasm.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  Dysphagia       Date:  2012-01-04       Impact factor: 3.438

Review 3.  Peroral endoscopic myotomy: An emerging minimally invasive procedure for achalasia.

Authors:  Yalini Vigneswaran; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-10-10

Review 4.  A comprehensive appraisal of the surgical treatment of diffuse esophageal spasm.

Authors:  Cristina Almansa; Ronald A Hinder; C Daniel Smith; Sami R Achem
Journal:  J Gastrointest Surg       Date:  2007-12-11       Impact factor: 3.452

5.  Comparison of thoracoscopic and laparoscopic Heller myotomy for achalasia.

Authors:  M G Patti; M Arcerito; M De Pinto; C V Feo; J Tong; W Gantert; L W Way
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

6.  Primary esophageal motility disorders: incisive decisions.

Authors:  G Triadafilopoulos
Journal:  West J Med       Date:  1997-04

Review 7.  Surgical treatment of primary esophageal motility disorders.

Authors:  Fernando A Herbella; Ana C Tineli; Jorge L Wilson; Jose C Del Grande
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

8.  Electrical stimulation of the vagus nerve restores motility in an animal model of achalasia.

Authors:  Yashodhan S Khajanchee; Roger VanAndel; Blair A Jobe; Michael J Barra; Paul D Hansen; Lee L Swanstrom
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

Review 9.  Management of spastic disorders of the esophagus.

Authors:  Sabine Roman; Peter J Kahrilas
Journal:  Gastroenterol Clin North Am       Date:  2013-01-04       Impact factor: 3.806

10.  Surgical treatment for nonspecific esophageal motility disorders.

Authors:  Takanori Inose; Tatsuya Miyazaki; Shigemasa Suzuki; Naritaka Tanaka; Makoto Sakai; Akihiko Sano; Takehiko Yokobori; Makoto Sohda; Masanobu Nakajima; Minoru Fukuchi; Hiroyuki Kato; Hiroyuki Kuwano
Journal:  Surg Today       Date:  2012-12-18       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.